RxDoctor Payments DataLook up a doctor →

Jason Mensah, DO

Psychiatry · Beaumont, TXNPI 1619137593

Payments from drug & device makers

$10,253,790in general payments, 2019–2025

Across 1,208 payments — averaging $8488.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$9.4M
  • Supernus Pharmaceuticals, Inc.$471K
  • AbbVie$157K
  • Boehringer Ingelheim International GmbH$90K
  • Axsome Therapeutics, Inc.$41K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$26K
  • plus $29K from 35 others
$252,778in research payments, 2019–2025

Across 6 payments — averaging $42,130 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$253K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,253,790 in reported general payments places this provider in the 95th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas

Medicare billing

Part B allowed, 2024
$58,640
Medicare patients
125
Services billed
526

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other psychiatry in Beaumont

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →